Villalaín González Cecilia, Herraiz García Ignacio, Fernández-Friera Leticia, Ruiz-Hurtado Gema, Morales Enrique, Solís Jorge, Galindo Alberto
Unidad de Medicina Fetal, Servicio de Obstetricia y Ginecología, Departamento de Salud Pública y Materno-Infantil, Hospital Universitario 12 de Octubre, Universidad Complutense de Madrid, Madrid, Spain; Instituto de Investigación del Hospital 12 de Octubre (imas12), Madrid, Spain; Primary Care Interventions to Prevent Maternal and Child Chronic Diseases of Perinatal and Developmental Origin (RICORS network), RD21/0012/0024, Instituto de Salud Carlos III, Madrid, Spain.
Hospital Universitario HM Montepríncipe-CIEC, Madrid, Spain; Centro Nacional de Investigaciones Cardiovasculares (CNIC), Madrid, Spain; Centro de Investigación Biomédica en Red de Enfermedades Cardiovasculares (CIBERCV), Hospital Universitario 12 de Octubre, Madrid, Spain.
Nefrologia (Engl Ed). 2023 May-Jun;43(3):269-280. doi: 10.1016/j.nefroe.2022.04.009. Epub 2023 Aug 25.
Cardiovascular (CVD) and chronic kidney disease (CKD) in women have unique risk factors related to hormonal status and obstetric history that must be taken into account. Pregnancy complications, such as preeclampsia (PE), can reveal a subclinical predisposition for the development of future disease that may help identify women who could benefit from early CVD and CKD prevention strategies.
Review of PE and its association with future development of CVD and CKD.
Multiple studies have established an association between PE and the development of ischemic heart disease, chronic hypertension, peripheral vascular disease, stroke and CKD. It has not been sufficiently clarified if this relation is a causal one or if it is mediated by common risk factors. Nevertheless, the presence of endothelial dysfunction and thrombotic microangiopathy during pregnancies complicated with PE makes us believe that PE may leave a long-term imprint. Early identification of women who have had a pregnancy complicated by PE becomes a window of opportunity to improve women's health through adequate follow-up and targeted preventive actions. Oxidative stress biomarkers and vascular ultrasound may play a key role in the early detection of this arterial damage.
The implementation of preventive multidisciplinary targeted strategies can help slow down CVD and CKD's natural history in women at risk through lifestyle modifications and adequate blood pressure control. Therefore, we propose a series of recommendations to guide the prediction and prevention of CVD and CKD throughout life of women with a history of PE.
女性心血管疾病(CVD)和慢性肾脏病(CKD)具有与激素状态和产科病史相关的独特危险因素,必须予以考虑。诸如子痫前期(PE)等妊娠并发症可能揭示未来疾病发展的亚临床易感性,这有助于识别可能从早期CVD和CKD预防策略中获益的女性。
回顾PE及其与CVD和CKD未来发展的关联。
多项研究已证实PE与缺血性心脏病、慢性高血压、外周血管疾病、中风和CKD的发生之间存在关联。这种关系是因果关系还是由共同危险因素介导,目前尚未得到充分阐明。然而,在合并PE的妊娠期间存在内皮功能障碍和血栓性微血管病,这使我们相信PE可能会留下长期印记。早期识别有PE合并妊娠史的女性成为通过充分随访和有针对性的预防措施改善女性健康的一个机会窗口。氧化应激生物标志物和血管超声可能在这种动脉损伤的早期检测中发挥关键作用。
实施预防性多学科针对性策略有助于通过生活方式改变和适当的血压控制来减缓有风险女性CVD和CKD的自然病程。因此,我们提出一系列建议,以指导对有PE病史女性一生中心血管疾病和慢性肾脏病的预测和预防。